Office of Research & Development |
|
Project Number: | I21BX006349-01 |
Title: | Offsetting CNS inflammatory damage with anti-CXCR3 antibody immunotherapy |
Principal Investigator: | Michal A. Olszewski |
Location: | Ann Arbor, MI |
Congressional District Code: | 12 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | January 2024 - December 2025 |
FY 2025 Funding Amount: | $83,000 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |